{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "26583936", "DateCompleted": {"Year": "2016", "Month": "04", "Day": "20"}, "DateRevised": {"Year": "2015", "Month": "12", "Day": "23"}, "Article": {"ArticleDate": [], "ELocationID": ["10.1039/c5np00049a"], "Language": ["eng"], "Journal": {"ISSN": "1460-4752", "JournalIssue": {"Volume": "33", "Issue": "1", "PubDate": {"Year": "2016", "Month": "Jan"}}, "Title": "Natural product reports", "ISOAbbreviation": "Nat Prod Rep"}, "ArticleTitle": "TCM, brain function and drug space.", "Pagination": {"StartPage": "6", "EndPage": "25", "MedlinePgn": "6-25"}, "Abstract": {"AbstractText": ["Covering: up to 2015. Traditional Chinese medicine has played a significant role in the mainstream healthcare system in China for thousands of years. Here, we summarize 84 major compounds from 15 selected herbal medicines targeting neurodegenerative diseases. We present a perspective based on the analysis of physicochemical properties of these TCM compounds, and comparison with current drugs and candidates for the treatment of Parkinson's and Alzheimer's disease. The results demonstrate that traditional Chinese medicines contain compounds possessing physicochemical properties that have excellent overlap with developed western medicines."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Eskitis Institute for Drug Discovery, Griffith University, Brisbane, QLD 4111, Australia. r.quinn@griffith.edu.au and State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China."}], "LastName": "Tang", "ForeName": "Chunping", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China and Eskitis-SIMM Joint Laboratory for Drug Discovery, Australia."}], "LastName": "Ye", "ForeName": "Yang", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Eskitis Institute for Drug Discovery, Griffith University, Brisbane, QLD 4111, Australia. r.quinn@griffith.edu.au and Eskitis-SIMM Joint Laboratory for Drug Discovery, Australia."}], "LastName": "Feng", "ForeName": "Yunjiang", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Eskitis Institute for Drug Discovery, Griffith University, Brisbane, QLD 4111, Australia. r.quinn@griffith.edu.au and Eskitis-SIMM Joint Laboratory for Drug Discovery, Australia."}], "LastName": "Quinn", "ForeName": "Ronald J", "Initials": "RJ"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Nat Prod Rep", "NlmUniqueID": "8502408", "ISSNLinking": "0265-0568"}, "MeshHeadingList": [{"QualifierName": ["drug therapy"], "DescriptorName": "Alzheimer Disease"}, {"QualifierName": ["physiopathology"], "DescriptorName": "Brain"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Medicine, Chinese Traditional"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Parkinson Disease"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2015", "Month": "11", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "11", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "4", "Day": "21", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["26583936", "10.1039/c5np00049a"]}}], "PubmedBookArticle": []}